Biosensors for Cancer Detection

Biosensors are devices that are designed to detect a specific biological analyte by essentially converting a biological entity (ie, protein, DNA, RNA) into an electrical signal that can be detected and analyzed. The use of biosensors in cancer detection and monitoring holds vast potential. Biosensors can be designed to detect emerging cancer biomarkers and to determine drug effectiveness at various target sites. Biosensor technology has the potential to provide fast and accurate detection, reliable imaging of cancer cells, and monitoring of angiogenesis and cancer metastasis, and the ability to determine the effectiveness of anticancer chemotherapy agents.

December 7, 2021

Label-Free Electrochemical Detection of the Cancer Biomarker Platelet-Derived Growth Factor Receptor in Human Serum and Cancer Cells.

ACS Biomaterials Science & Engineering
Chandrababu RejeethSamson Afewerki
December 6, 2021
Review

Can the application of graphene oxide contribute to the fight against COVID-19? Antiviral activity, diagnosis and prevention.

Current Research in Pharmacology and Drug Discovery
Asmaa RhazouaniAziz Faissal
December 6, 2021

A Fluorescent Aptasensor Based on Assembled G-Quadruplex and Thioflavin T for the Detection of Biomarker VEGF165.

Frontiers in Bioengineering and Biotechnology
Xin ZhengXiaobo Hu
December 4, 2021
Review

Magnetic frequency mixing technological advances for the practical improvement of point-of-care testing.

Biotechnology and Bioengineering
Tangan LiDaxiang Cui
December 4, 2021
Review

Biosensor approaches on the diagnosis of neurodegenerative diseases: Sensing the past to the future.

Journal of Pharmaceutical and Biomedical Analysis
Münteha Nur Sonuç Karaboğa, Mustafa Kemal Sezgintürk
December 4, 2021
Open Access

A Versatile Multichannel Instrument for Measurement of Ratiometric Fluorescence Intensity and Phosphorescence Lifetime.

IEEE Access : Practical Innovations, Open Solutions
Amir Tofighi ZavarehMichael J McShane
December 3, 2021
Review

Shedding Light on DNA-Based Nanoprobes for Live-Cell MicroRNA Imaging.

Small
Fan YangXueji Zhang
December 2, 2021

Engineered l-Lactate Responding Promoter System Operating in Glucose-Rich and Anoxic Environments.

ACS Synthetic Biology
Ana ZúñigaJerome Bonnet
December 2, 2021

A Multiplexable Plasmonic Hairpin-DNA Sensor Based On Target-specific Tether Dynamics.

ACS Sensors
Jeanne Elisabeth van DongenLoes Irene Segerink
December 2, 2021

Microfluidic organ-on-chip system for multi-analyte monitoring of metabolites in 3D cell cultures.

Lab on a Chip
Johannes DornhofAndreas Weltin
December 1, 2021

Template-free, controllable and scalable synthesis of poly(5-aminoindole) nanoparticles for printable electrochemical immunosensor with ultra-high sensitivity.

Journal of Materials Chemistry. B, Materials for Biology and Medicine
Taotao YangZhiqiang Luo

Sign up to follow this feed and discover related papers.

Related Feeds

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.

CAR-T cells

Chimeric antigen receptor (CAR) T cells are cells that are genetically engineered to recognize and target specific proteins. The ability of these cells to recognize cancer antigens and eliminate tumor cells have transformed cancer immunotherapy approaches. Here is the latest research on CAR-T cells.

Cancer -Omics

A variety of different high-throughput technologies can be used to identify the complete catalog of changes that characterize the molecular profile of cohorts of tumor samples. Discover the latest insights gained from cancer 'omics' in this feed.

Cancer Cell Invasion: Nanomedicine

Nanomedicine is a promising alternative for cancer detection and therapy that utilizes nanoparticles, such as liposomes. Nanoparticles can potentially target cancer cell invasion and metastasis. Discover the latest research on Cancer Cell Invasion: Nanomedicine here.

Cancer Disparities

Cancer disparities refers to differences in cancer outcomes (e.g., number of cancer cases, related health complications) across population groups.

Cancer Immunotherapy

Cancer immunotherapy is an important field of research that is looking at controlling cancer and tumor growth by activating the individuals own immune system. Recent studies have utilized chimeric antigen receptor t-cell therapy, immune checkpoint inhibitors and neoantigen vaccines. Discover the latest research on cancer immunotherapy here.

Cancer Incidence & Mortality

Cancer has emerged as a global concern due to its increase in incidence and mortality. Efforts are underway to evaluate and develop action plans to reduce the global burden of cancer. Currently, lung cancer, breast cancer and prostate cancer are the leading causes of cancer mortality. Here is the latest research on cancer incidence and mortality.

Cancer Metabolic Reprogramming

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

Cancer Metabolism: Therapeutic Targets

Targeting the mechanisms by which cancer cells acquire energy for metabolic needs is a therapeutic target. Discover the latest research on cancer metabolism and therapeutic targets.

© 2021 Meta ULC. All rights reserved
/feed-previews/biosensors-for-cancer-detection/dc1f1dc3-1c11-46a5-a5bd-6f3e8b5111b4